21
Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information Service The Prince Charles Hospital, Queensland Health Brisbane Ian Smith St Andrews Medical Institute St Andrews War Memorial Hospital, Uniting Healthcare, Brisbane

Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Embed Size (px)

Citation preview

Page 1: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Squeezing Juice from Clinical Data Repositories:

Information for Patient Management and

ABF Revenue

Susan SmithCardiothoracic Surgical Clinical Information ServiceThe Prince Charles Hospital, Queensland Health, BrisbaneIan SmithSt Andrews Medical InstituteSt Andrews War Memorial Hospital, Uniting Healthcare, Brisbane

Page 2: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Background

A variety of Clinical Information Systems (CIS) now exist • Operational & patient management systems eg

– Medical imaging, diagnostics– Pathology– EMR – ED, Anaesthetics, Operating Theatre, Oncology,

GP/Community, etc• Managerial/tactical

– Bookings/referral systems• Strategic

– Registries, vital statistics– Research databases

Page 3: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Increasing pressure for secondary use of clinical information to support decision-making due to a number

of drivers: • Health System Reform, Restructure & Transformation• Information Revolution• ‘Evidence-Based’ paradigm• Accountability & Performance monitoring• Q&S• Multidisciplinary Research Activities• New Analytical tools

Background

Page 4: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Increasing Development of analytical tools/technology eg• Data Integration

– Data Warehousing– In-line memory– Hadoop

• Business/Clinical Intelligence– Interactive reports– Dashboards

• Analytics– Statistical Process Control for Healthcare– Geospatial Analytics– Visual Analytics– Data Mining– Predictive statistics

Background

Page 5: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

For the process of secondary data use to support decision-making to occur we need to extract meaningful information from growing stores of data

DATA DATA --> INFORMATION > INFORMATION --> KNOWLEDGE > KNOWLEDGE --> WISDOM > WISDOM --> PRACTICE/POLICY> PRACTICE/POLICY

Relationship of Data and Knowledge:Relationship of Data and Knowledge:

Source: L Ryan, Source: L Ryan, HIC 2007HIC 2007

= Evidence Based = Evidence Based HealthcareHealthcare

= Evidence Based = Evidence Based Service Service ManagementManagement

= Evidence Based = Evidence Based Decision MakingDecision Making

_________Background

Page 6: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Purpose of CSCIS• Provide accurate and reliable, clinically actionable information, from

data available relating to Cardiothoracic surgical practice, to support/facilitate the best patient outcomes

• Primary functions relate to:– Outcomes Data Acquisition, – CTSx Morbidity & Mortality Peer Review Reporting/Support, – Clinical Audit Reporting, – Supporting Clinical Research cohort definition,– Support retrospective observational analyses

Cardiothoracic Surgery Clinical Information Service

Page 7: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

To perform these duties CSCIS have:• Data Registry Database & Ancilliary data repositories, DLU• Tools – Access, Excel, SPSS, QI Macros• Clinical Informatics

– Clinical Knowledge & experience (RN x3, Hosp scientist)PLUS– Health Informatics knowledge and experience (HIMOx2, MHlth

Sci (CDM), M Epi)PLUS– Public Health/Epidemiology/Biostatistics skills (Outcomes /Audit/

analysis reporting, SPSS training)

Cardiothoracic Surgery Clinical Information Service

Page 8: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

“Succeeding with … analytics requires a database and information infrastructure that supports it, plus a culture that bridges the gap between DBAs and analysts”

Wayne Eckerson , Director of Research for The Data Warehousing Institute

- Assuming that the gap between analysts and clinicians is also bridged!

- Socio-technical and cultural issue

Cardiothoracic Surgery Clinical Information Service

Page 9: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Two examples of extending the use of registry-based information:

• Activity Based Funding DRG coding Audit against Clinical Data• Analysis of Trends in Reoperation for Bleeding post CABG

Cardiothoracic Surgery Clinical Information Service

Page 10: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Data Audit and exchange with Medical Records FACT group to optimise accuracy of DRG allocation

Levels of crosscheck for data capture• Cardiac Surgery Level-

– Referencing against Clinical CTSx Register data, crosscheck DRG allocations to identify any inconsistent with cardiac surgery codes

– eg cost difference: from $1,750 - $40,960• Procedure Level -

– confirm Valve, CABG, Other CTSx eg all concomitant procedures, complexity of procedure, Other CardThor related DRG appropriate

– eg cost difference: from $1,750 - $40,960• Complication Comorbidity Levels (CCLs) -

– Sort Clinical Data records by Euroscore Risk Score (Clinical Severity index)– Cross check Clinical data with DRG coding for records with Euroscore >8%– If high risk score cases not coded to appropriate DRG codes, check for capture of

comorbidities• Invasive investigations Level

– eg sort Clinical data for inpatient preop coronary angiogram procedure, crosscheck against DRG allocation

– eg cost difference: up to $13,456

1. ABF Project

Page 11: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

This could be done by audit of DRG output against charts, however this would be more costly and by use of the clinical data we can target the critical procedures, rather than review all cases.

ie Pareto’s Principle or Juran’s observation of "vital few and trivial many":

80% of cost due to 20% errors

1. ABF Project

Page 12: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Requirements:• Clinical Data repository + DRG expertise + Clinical DM expertise• Good relationship with Med Recs• Time allocation – approx 2 hrs per month

(for 1350 cases (1200 discharges) pa of CTSx complexity)

Limitations:• Nb some complications are inherent to particular DRGs ie can’t

double capture• Still require Med Recs to correct coding Coding module• Time delay /can’t change after submission• Can’t audit everything

Estimated Benefits:• Estimated increased revenue identified Jul-Jan: at least $200,000• Audit feedback noticeably improves coding quality

1. ABF Project

Page 13: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Bleeding is a significant consequence of Cardiac Surgery. • Reported rates vary from 2-8%• TPCH identified increasing rate over 2002-2010 through regular

peer review M&M meetings

How do we use our data to investigate this?

• Highly complex mechanism with many predictors and confounders

– Physiological patient factors– Procedural factors– Care management factors

2. Analysis of Trends in

Reoperation for Bleeding post-CABG.

Page 14: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Data Issues:– Some good quality data

• eg primary outcome: reoperation– Incomplete data on potential modifiers of bleeding

rates eg• Preop antiplatelets therapy (poor documentation)• Use of antifibrinolytics – aprotinin, aminocaproic acid, TXA

(not in CTSx Register – imprest stock)• Other system modifiers such as use of clinical pathway not

captured (eg ACS)

2. Analysis of Trends in

Reoperation for Bleeding post-CABG.

Page 15: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Analysis methodology options– Traditional multivariate regression does not reveal

factors that explain the increasing trend, difficult to discern trends for different procedures, etc

– Statistical Process Control• Much used in industrial and engineering processes• Being adopted more widely in healthcare• Exponentially Weighted Moving Average (EWMA)

statistically robust and clinically intuitively interpretable

2. Analysis of Trends in

Reoperation for Bleeding post-CABG.

Page 16: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

EWMA Reoperation for Bleeding- All Cardiac Surgery

0.07UCL

0.06CL

0.04LCL

0.00

0.01

0.02

0.03

0.04

0.05

0.06

0.07

0.08

0.09

0.10

1Q02

2Q02

3Q02

4Q02

1Q03

2Q03

3Q03

4Q03

1Q04

2Q04

3Q04

4Q04

1Q05

2Q05

3Q05

4Q05

1Q06

2Q06

3Q06

4Q06

1Q07

2Q07

3Q07

4Q07

1Q08

2Q08

3Q08

4Q08

1Q09

2Q09

3Q09

4Q09

1Q10

2Q10

3Q10

4Q10

Quarter, Years

Inci

den

ce A

vera

ge

2. Analysis of Trends in Reoperation for Bleeding post-CABG.

Page 17: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

EWMA Reoperation for Bleeding - All Non-CABG

0.12UCL

0.08CL

0.04LCL

0.00

0.02

0.04

0.06

0.08

0.10

0.12

1Q02

2Q02

3Q02

4Q02

1Q03

2Q03

3Q03

4Q03

1Q04

2Q04

3Q04

4Q04

1Q05

2Q05

3Q05

4Q05

1Q06

2Q06

3Q06

4Q06

1Q07

2Q07

3Q07

4Q07

1Q08

2Q08

3Q08

4Q08

1Q09

2Q09

3Q09

4Q09

1Q10

2Q10

3Q10

4Q10

Quarter, Year

Inci

den

ce A

vera

ge

EWMA Reoperation for Bleeding - Isol CABG

UCL 0.05

CL 0.03

LCL 0.02

0.00

0.01

0.02

0.03

0.04

0.05

0.06

0.07

0.08

0.09

0.10

1Q02

2Q02

3Q02

4Q02

1Q03

2Q03

3Q03

4Q03

1Q04

2Q04

3Q04

4Q04

1Q05

2Q05

3Q05

4Q05

1Q06

2Q06

3Q06

4Q06

1Q07

2Q07

3Q07

4Q07

1Q08

2Q08

3Q08

4Q08

1Q09

2Q09

3Q09

4Q09

1Q10

2Q10

3Q10

4Q10

Quarter, Year

Inci

den

ce A

vera

ge

2. Analysis of Trends in Reoperation for Bleeding post-CABG.

Page 18: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

VariableOR Sig.

95% C.I. for OR

zLower Upper

BMI 0.917 0.004 0.865 0.973 -0.10721

Aborig/TSI 4.357 0.003 1.661 11.430 1.475711

Diabetes 0.490 0.038 0.250 0.961 -0.58104

Preop Resus within 1hr 86.198 0.003 4.723 1573.327 4.537611

To MOT direct from Cath Lab

15.338 0.001 2.964 79.363 2.577087

Constant -0.81216

Multivariate regression Odds Ratios for predictors of reoperation for bleeding following isolated CABG, 2002-2005.

0

0.01

0.02

0.03

0.04

0.05

0.06

0.07

0.080

200

400

600

800

1000

1200

1400

1600

1800

2000

2200

2400

2600

2800

3000

3200

3400

3600

3800

4000

4200

4400

4600

4800

5000

5200

5400

5600

5800

6000

6200

Patient Number

Reo

per

atio

n R

ate

EWMA (Exp)

UCL

LCL

EWMA (Obs)

2. Analysis of Trends in Reoperation for Bleeding post-CABG.

Expected risk (green) with observed (blue) reoperation for bleeding following isolated CABG, 2002-2005.

Page 19: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Elective

Non-ElectiveReturn to MOT For Non-Elective Vs Elective CABG Only Cases

0.029

0.024

0.020

0.000

0.005

0.010

0.015

0.020

0.025

0.030

0.035

0.040

0.045

0.050

7 825 1689 2260 2817 3348 3752 4184 4573 4960 5356 5703 6031

Patient Number

Av

era

ge

in

cid

en

ce

EWMA Reoperation for Bleeding - Isol CABG

UCL

0.05

CL 0.03

LCL

0.02

0.00

0.01

0.02

0.03

0.04

0.05

0.06

1Q02

2Q02

3Q02

4Q02

1Q03

2Q03

3Q03

4Q03

1Q04

2Q04

3Q04

4Q04

1Q05

2Q05

3Q05

4Q05

1Q06

2Q06

3Q06

4Q06

1Q07

2Q07

3Q07

4Q07

1Q08

2Q08

3Q08

4Q08

1Q09

2Q09

3Q09

4Q09

1Q10

2Q10

3Q10

4Q10

Quarter, Year

Incid

en

ce A

vera

ge

ACS Pathwys introduced

Aprotinin withdrawn

TXA use reduced

TXA introduced

TXA Peak use

Page 20: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Requirements– Analytical tools: Excel, SPSS, QI Macros – Expertise: Clinical Data Management, Epidemiological, Statistical

Process Control methodology– Resources: fte, financial & clinical support

Limitations: – Indirect /circumstantial evidence– Caveats re data quality

Benefit: – How can this enhance clinical decision-making?– How can this direct further work?

2. Analysis of Trends in

Reoperation for Bleeding post-CABG.

Page 21: Squeezing Juice from Clinical Data Repositories: Information for Patient Management and ABF Revenue Susan Smith Cardiothoracic Surgical Clinical Information

Registry collected data can support a variety of uses

Requires appropriate tools, expertise and resources

Can be shown to have tangible and intangible benefits

Conclusions